These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8033931)

  • 21. Severe, isolated thrombocytopenia under polytherapy with carbamazepine and valproate.
    Finsterer J; Pelzl G; Hess B
    Psychiatry Clin Neurosci; 2001 Aug; 55(4):423-6. PubMed ID: 11442896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valproic acid and thrombocytopenia. Case report.
    Patel CC; Church S; Reilly KM
    J Ky Med Assoc; 1982 Apr; 80(4):213-5. PubMed ID: 6808068
    [No Abstract]   [Full Text] [Related]  

  • 23. The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical Data.
    Buoli M; Serati M; Botturi A; Altamura AC
    Drugs R D; 2018 Mar; 18(1):1-5. PubMed ID: 29260458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium valproate and bone marrow suppression.
    Smith FR; Boots M
    Ann Neurol; 1980 Aug; 8(2):197-9. PubMed ID: 6775583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombocytopenia secondary to high valproate levels in children with epilepsy.
    Delgado MR; Riela AR; Mills J; Browne R; Roach ES
    J Child Neurol; 1994 Jul; 9(3):311-4. PubMed ID: 7930412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trilineage hematopoietic toxicity associated with valproic acid therapy.
    Bottom KS; Adams DM; Mann KP; Ware RE
    J Pediatr Hematol Oncol; 1997; 19(1):73-6. PubMed ID: 9065723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased platelet count in children with epilepsy treated with valproate and its relationship to the immature platelet fraction.
    Kurahashi H; Takami A; Murotani K; Numoto S; Okumura A
    Int J Hematol; 2018 Jan; 107(1):105-111. PubMed ID: 28879549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium valproate and platelet-count.
    Raworth RE; Birchall G
    Lancet; 1978 Mar; 1(8065):670-1. PubMed ID: 76214
    [No Abstract]   [Full Text] [Related]  

  • 29. Fatality from hepatitis A in a child taking valproate.
    Fayad M; Choueiri R; Mikati M
    J Child Neurol; 2000 Feb; 15(2):135-6. PubMed ID: 10695901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Valproate-induced worsening of seizures: clue to underlying diagnosis.
    Dhamija R; Gavrilova RH; Wirrell EC
    J Child Neurol; 2011 Oct; 26(10):1319-21. PubMed ID: 21454832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk.
    Tohen M; Castillo J; Baldessarini RJ; Zarate C; Kando JC
    Am J Psychiatry; 1995 Mar; 152(3):413-8. PubMed ID: 7864268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valproate Induced Acute Pancreatitis - A Unique Case Report.
    Chauhan V; Sharma M; Kapur A; Garg GK
    Curr Drug Saf; 2022; 17(4):387-389. PubMed ID: 35196972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pure red cell aplasia associated with sodium valproate therapy.
    MacDougall LG
    JAMA; 1982 Jan; 247(1):53-4. PubMed ID: 6796707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: case report.
    Cheung E; Wong V; Fung CW
    J Child Neurol; 2005 Feb; 20(2):157-60. PubMed ID: 15794187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgM platelet autoantibody due to sodium valproate.
    Sandler RM; Emberson C; Roberts GE; Voak D; Darnborough J; Heeley AF
    Br Med J; 1978 Dec; 2(6153):1683-4. PubMed ID: 367512
    [No Abstract]   [Full Text] [Related]  

  • 36. Valproic acid and immune thrombocytopenia.
    Barr RD; Copeland SA; Stockwell ML; Morris N; Kelton JC
    Arch Dis Child; 1982 Sep; 57(9):681-4. PubMed ID: 6812506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valproate-induced hyperammonemia as a cause of altered mental status.
    Feil D; Chuang K; Sultzer DL
    Am J Geriatr Psychiatry; 2002; 10(4):476-8. PubMed ID: 12095907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valproic acid and thrombocytopenia: cross-sectional study.
    Ko CH; Kong CK; Tse PW
    Hong Kong Med J; 2001 Mar; 7(1):15-21. PubMed ID: 11406671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Valproate-induced hyperammonemic encephalopathy.
    Chou HF; Yang RC; Chen CY; Jong YJ
    Pediatr Neonatol; 2008 Oct; 49(5):201-4. PubMed ID: 19133574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of pure red cell aplasia associated with sodium valproate therapy].
    Anzai K; Kitajima H; Kubo M
    Rinsho Ketsueki; 1994 Mar; 35(3):286-90. PubMed ID: 8158850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.